Skip to main content
Aggregate STAT News 生物医药 1 Sep 2026 - 00:32

STAT+: GLP-1 drugs are almost single-handedly forcing employers to reconsider workers’ health care

RSS 官方收录 · 可信分层展示

关键摘要

This is the online version of STAT’s weekly email newsletter Health Care Inc.Sign up here.…

  • If you’re not doing anything tomorrow at 2 p.
  • ET, come watch a webinar about how federal health agencies are stonewa…
  • I’ll be on the panel with Sheryl Gay Stolberg of the New York Times, R…

摘要引擎:抽取

正文提要

This is the online version of STAT’s weekly email newsletter Health Care Inc. Sign up here.

If you’re not doing anything tomorrow at 2 p.m. ET, come watch a webinar about how federal health agencies are stonewalling the press. I’ll be on the panel with Sheryl Gay Stolberg of the New York Times, Robert King of Politico, Caitlin Vogus of the Freedom of the Press Foundation, and Joyce Frieden of MedPage Today. RSVP here, and as always, hurl your feedback at me: bob.herman@statnews.com.

Are GLP-1s breaking employers?

GLP-1 drugs are almost single-handedly forcing employers to reconsider how they pay for their workers’ care.

Continue to STAT+ to read the full story…

打开官方原文 站点原文页 可信分区 本信源更多 今日简报 分享图 RSS 稍后再看列表